infecti
diseas
still
remain
one
biggest
challeng
human
health
order
gain
better
understand
pathogenesi
infecti
diseas
develop
effect
diagnost
tool
therapeut
agent
prevent
vaccin
suitabl
anim
model
repres
characterist
infecti
requir
syrian
hamster
immun
respons
infecti
pathogen
similar
human
model
advantag
studi
pathogenesi
infect
includ
postbacteri
viral
parasit
pathogen
along
assess
efficaci
interact
medic
vaccin
pathogen
review
summar
current
statu
syrian
hamster
model
use
understand
underli
mechan
pathogen
infect
addit
use
drug
discoveri
platform
provid
strong
rational
select
syrian
hamster
anim
model
biomed
research
challeng
use
syrian
hamster
altern
anim
model
research
infecti
diseas
also
address
accord
data
releas
world
health
organ
infecti
agent
caus
lower
respiratori
infect
diarrheal
diseas
tuberculosi
rank
top
ten
caus
death
worldwid
result
million
death
clear
need
improv
understand
diseas
pathogen
agent
order
develop
effect
drug
vaccin
end
need
suitabl
anim
model
accur
mimic
pathogenesi
infect
infect
usual
induc
complex
process
host
immun
respons
vitro
experi
unabl
simul
vivo
model
accur
assess
complex
host
respons
allow
efficaci
advers
effect
drug
vaccin
evalu
syrian
hamster
mesocricetu
auratu
use
anim
model
studi
humanassoci
diseas
year
number
studi
document
syrian
hamster
repres
better
model
analysi
viral
infect
compar
murin
model
similar
human
regard
diseas
symptom
pathognesi
immun
respons
greater
demonstr
us
other
human
cytokin
includ
granulocytemacrophag
colonystimul
factor
gmcsf
fulli
function
hamster
model
mous
model
togeth
advantag
fast
reproduct
rate
eas
handl
syrian
hamster
superior
choic
compar
small
anim
although
syrian
hamster
histor
use
diseas
research
valu
anim
model
studi
infecti
diseas
recent
realiz
advanc
gene
edit
technolog
popular
increas
significantli
figur
use
genet
engin
syrian
hamster
gesh
model
critic
understand
diseas
progress
develop
prophylact
therapeut
treatment
regimen
first
gene
knockout
ko
syrian
hamster
develop
use
system
target
hamster
germlin
crucial
element
type
interferon
ifn
signal
transduct
pathway
hamster
model
emerg
small
anim
model
permiss
adenoviru
adv
infect
thu
ko
model
critic
character
adenoviru
pathogenesi
syrian
hamster
ideal
small
anim
model
studi
diseas
caus
viru
infect
previou
studi
shown
humanspecif
virus
also
infect
replic
caus
similar
patholog
alter
syrian
hamster
particular
syrian
hamster
recogn
valuabl
model
studi
emerg
acut
human
viral
diseas
caus
highli
pathogen
rna
virus
thu
anim
great
valu
test
potenti
vaccin
new
therapeut
drug
human
use
present
differ
virus
investig
use
syrian
hamster
viral
infect
studi
explor
futur
tabl
review
focu
six
virus
use
syrian
hamster
provid
valuabl
insight
diseas
pathogenesi
search
perform
keyword
syrian
hamster
golden
hamster
model
viral
viru
bacteria
infect
diseas
transmit
via
bite
infect
arthropod
mosquito
human
major
wnv
infect
asymptomat
infect
individu
develop
symptomat
west
nile
fever
wnf
howev
wnv
import
emerg
neurotrop
viru
caus
sever
enceph
human
pose
signific
threat
global
health
syrian
hamster
readili
infect
mosquito
bite
ingest
oral
needl
inocul
infect
hamster
develop
viremia
ill
symptom
similar
experienc
human
infect
use
hamster
model
xiao
et
al
observ
histolog
abnorm
appear
viral
antigen
brain
first
follow
spinal
cord
infect
eventu
lead
acut
central
nervou
system
cn
injuri
infect
hamster
develop
neurolog
diseas
associ
suppress
diaphragmat
electromyograph
emg
infect
medulla
oblongata
yfv
arthropodborn
viru
genu
flaviviru
famili
flavivirida
high
morbid
mortal
rate
region
subsaharan
africa
south
america
one
first
virus
human
identifi
isol
propag
vitro
studi
genom
sequenc
studi
infect
mechan
yfv
histor
hinder
lack
appropri
small
anim
model
nonhuman
primat
nhp
model
typic
use
recent
sever
research
group
gener
anim
model
use
syrian
hamster
success
infect
yfv
mcarthur
et
al
report
adapt
viral
strain
asibihamst
allow
reproduct
yellow
fever
diseas
hamster
featur
similar
human
diseas
studi
also
shown
infect
syrian
hamster
result
immun
respons
correspond
observ
infect
human
mark
increas
spleen
kidney
heart
reduc
level
seen
liver
addit
studi
found
increas
level
reduc
level
liver
spleen
heart
earli
midstag
infect
syrian
hamster
use
studi
pathogenesi
yfv
infect
valid
antivir
drug
antivir
therapi
recent
find
shown
treatment
antivir
compound
cmethyl
cytidin
nipah
paramyxoviru
genu
henipaviru
famili
paramyxovirida
high
fatal
rate
infect
human
usual
caus
sever
encephalit
respiratori
diseas
inocul
nipah
viru
niv
syrian
hamster
also
develop
characterisit
neurolog
diseas
similar
symptom
human
infect
patholog
lesion
sever
extens
hamster
brain
viral
antigen
rna
detect
neuron
lung
kidney
spleen
syrian
hamster
major
niv
infect
studi
treat
intraperiton
ip
inject
intranas
deliveri
model
reveal
differ
inocul
method
caus
divers
patholog
respons
wong
work
ip
inject
niv
syrian
hamster
caus
primarili
neurolog
diseas
deliveri
develop
neurolog
symptom
well
labor
breath
due
lung
infect
final
stage
diseas
diseas
progress
usual
much
rapid
time
death
postinfect
shorter
follow
intraperiton
rather
intranas
inocul
sinc
syrian
hamster
shown
suitabl
studi
niv
infect
use
studi
viral
transmiss
demonstr
nipah
viru
transmit
effici
via
direct
contact
ineffici
via
fomit
via
aerosol
regard
use
model
develop
diseas
treatment
prophylaxi
recent
studi
shown
pretreat
poli
poli
c
u
significantli
decreas
mortal
caus
niv
infect
syrian
hamster
addit
model
use
platform
evalu
vaccin
niv
walpita
et
al
discov
purifi
nivlik
particl
vlp
protect
syrian
hamster
use
either
multipledos
singledos
vaccin
regimen
follow
niv
challeng
ebola
viru
ebov
one
five
known
virus
within
genu
ebolaviru
famili
filovirida
classifi
biosafeti
level
pathogen
syrian
hamster
effect
infect
mous
adapt
ebov
addit
display
major
hallmark
infect
pathogenesi
seen
human
nonhuman
primat
nhp
syrian
hamster
could
inocul
via
intraperiton
inject
mous
adapt
zair
ebola
viru
mazebov
patholog
caus
infect
similar
human
includ
signific
spleen
liver
damag
cytokin
dysregul
sever
coagulopathi
lymphocyt
apoptosi
infect
organ
necrosi
apoptosi
immun
respons
infect
syrian
hamster
includ
activ
cell
antibodi
product
recent
studi
result
ebola
viru
infect
hamster
demonstr
cell
requir
natur
immun
antibodi
respons
requir
immun
viru
model
syrian
hamster
use
evalu
bival
vaccin
compris
recombin
vesicular
stomat
viru
vsv
express
two
differ
immunogen
deriv
zebov
envelop
glycoprotein
and
viru
andv
result
show
singl
immun
vaccin
provid
hamster
complet
steril
protect
lethal
challeng
mazebov
andv
marburg
viru
marv
also
neg
sens
rna
viru
belong
famili
filovirida
caus
hemorrhag
fever
syrian
hamster
also
ideal
anim
model
studi
seri
human
bacteri
parasit
infect
applic
wellreport
literatur
tabl
among
pathogen
studi
babesiosi
leptospirosi
leishmaniasi
caus
fatal
infect
studi
viru
pathogenesi
valu
syrian
hamster
model
reflect
studi
patholog
immun
respons
infect
also
discoveri
potenti
drug
treatment
pathogen
leptospira
interrogan
spirochet
bacteria
respons
leptospirosi
widespread
emerg
neglect
zoonot
syrian
hamster
prefer
model
studi
infect
serovar
leptospira
interrogan
bacteria
travel
rapidli
bloodstream
via
lymphat
frontier
immunolog
wwwfrontiersinorg
invad
tissu
infect
organ
prior
death
hamster
similar
human
presenc
leptospira
interrogan
detect
liver
kidney
destruct
hepatocyt
junction
lead
jaundic
thrombot
glomerulopathi
interstiti
nephriti
infect
anim
develop
enhanc
express
proinflammatori
cytokin
peripher
blood
cell
dramat
imbal
cytokin
product
upon
leptospira
infect
might
play
import
role
develop
sever
leptospirosi
sinc
syrian
hamster
shown
suitabl
model
use
test
efficaci
vaccin
diseas
palaniappan
et
al
demonstr
immun
syrian
hamster
recombin
liga
rliga
prevent
fatal
decreas
histopatholog
lesion
kidney
inhibit
growth
organ
anoth
studi
vaccin
use
conserv
region
leptospir
immunoglobulinlik
b
protein
ligb
aluminum
hydroxid
ah
significantli
increas
igg
igm
level
hamster
protect
anim
mortal
challeng
clostridium
difficil
diseas
caus
clostridium
difficil
infect
cdi
one
common
infecti
diseas
worldwid
increas
threat
morbid
mortal
caus
infect
mostli
due
emerg
hypervirul
strain
increas
use
misus
antibiot
use
mous
anim
model
unabl
provid
cdi
drug
discoveri
necessari
find
new
anim
model
sever
group
gener
syrian
hamster
model
cdi
develop
mani
clinic
symptom
observ
infect
human
studi
syrian
hamster
condit
singl
subcutan
inject
clindamycin
induc
clostridium
difficil
coliti
model
use
infect
model
efficaci
antibiot
clostridium
difficil
assess
oral
mixtur
kefirisol
bacteria
yeast
prevent
diarrhea
enterocol
trigger
clostridium
difficil
test
viscer
leishmaniasi
vl
also
known
kalaazar
sever
form
leishmaniasi
caus
leishmania
donovani
leishmania
infantum
leishmania
chagasi
america
syrian
hamster
highli
suscept
infect
viscer
leishmania
speci
consid
best
experiment
model
studi
vl
reproduc
clinicopatholog
featur
human
diseas
quit
distinct
note
murin
model
infect
major
studi
anim
infect
intracardi
rout
infect
anim
demonstr
upregul
express
cytokin
mrna
spleen
limit
induct
mrna
murin
model
leishmania
control
nitric
oxid
gener
howev
hamster
human
role
macrophag
function
induc
synthetas
ino
mrna
detect
liver
spleen
hamster
may
explain
uncontrol
parasit
replic
occur
hamster
human
despit
induct
strong
cytokin
respons
besid
leishmania
donovani
leishmania
infantum
also
studi
use
syrian
hamster
model
moreira
et
al
gener
model
use
syrian
hamster
featur
similar
human
clinic
pictur
leishmania
infantum
infect
anim
develop
hepatosplenomegali
sever
weight
loss
anemia
leucopenia
studi
found
increas
level
igg
hamster
infect
leishmania
infantum
similar
human
syrian
hamster
develop
progress
fatal
diseas
major
site
parasit
replic
liver
spleen
bone
marrow
eventu
caus
death
host
infect
hamster
show
strong
humor
respons
leishmania
antigen
high
antibodi
level
studi
test
immun
dna
plasmid
code
salivari
protein
lu
longipalpi
protein
protect
hamster
fatal
outcom
vl
entamoeba
histolytica
popular
protozoan
parasit
caus
amebiasi
human
major
sourc
morbid
mortal
develop
countri
parasit
entamoeba
histolytica
produc
ameb
coliti
ameb
liver
abscess
ala
syrian
hamster
success
infect
entamoeba
histolytica
similar
symptom
human
infect
main
extraintestin
complic
ala
also
found
hamster
hamster
liver
recruit
neutrophil
initi
host
respons
entamoeba
histolytica
infect
studi
indic
leukocyt
induc
entamoeba
histolytica
trophozoit
undergo
cell
death
although
antiparasit
drug
metronidazol
exist
side
effect
toxic
exist
patient
thu
model
use
develop
altern
therapeut
agent
one
research
group
show
bovin
lactoferrin
protect
hepat
amoebiasi
syrian
hamster
model
hamster
also
use
show
intraperiton
inject
entamoeba
histolytica
surfac
metalloproteas
antigen
vaccin
protect
ameb
liver
abscess
studi
immun
stimul
robust
igg
antibodi
respons
igg
bound
surfac
entamoeba
histolytica
trophozoit
acceler
ameb
lysi
via
activ
classic
complement
cascad
anim
model
use
entamoeba
histolytica
infect
use
show
baculoviru
drive
express
gallectin
fragment
administeredvia
intramuscular
inject
increas
ifn
level
liver
protect
ala
schistosoma
haematobium
urinari
blood
fluke
etiolog
agent
urogenit
schistosomiasi
sourc
morbid
mortal
million
peopl
worldwid
review
describ
use
syrian
hamster
model
extraordinarili
effect
relev
platform
evalu
molecular
mechan
immun
respons
infecti
diseas
studi
focu
sever
infecti
pathogen
includ
viral
parasit
bacteri
origin
result
indic
syrian
hamster
immun
respons
physiolog
similar
human
immun
respons
compar
anim
thu
offer
uniqu
advantag
studi
diseas
pathogenesi
novel
drug
treatment
discoveri
futur
studi
consid
determin
addit
similar
syrian
hamster
human
immun
respons
activ
pathogen
manipul
host
metabol
increas
research
effort
ultim
allow
develop
new
technolog
tool
studi
syrian
hamster
accur
sequenc
technolog
along
specif
antibodi
hamster
protein
current
limit
comparison
similar
tool
studi
murin
respons
infect
believ
recent
advanc
syrian
hamster
model
contribut
enorm
understand
infecti
diseas
diseas
manag
demonstr
strong
potenti
futur
research
develop
antivir
drug
discoveri
howev
discuss
lack
research
tool
repres
major
barrier
effect
use
syrian
hamster
model
immunolog
reagent
exam
host
immun
respons
particular
gene
express
transgen
diseas
model
requir
complet
evalu
valu
model
overcom
research
group
develop
identifi
consider
number
antibodi
syrian
hamster
tabl
hamster
specif
quantit
realtim
pcr
rtqpcr
transcriptom
analysi
microarray
also
develop
strikingli
technolog
rapidli
sped
creation
transgen
syrian
hamster
diseas
model
tool
overcom
limit
research
use
syrian
hamster
open
power
platform
recapitul
human
diseas
pathogensi
